Smithkline Beecham
GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company with global headquarters in London, England. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham.[n 1] GSK is the tenth largest pharmaceutical company and #294 on the 2022 Fortune Global 500, ranked behind other pharmaceutical companies China Resources, Sinopharm, Johnson & Johnson, Pfizer, Roche, AbbVie, Novartis, Bayer, and Merck.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Avaglim | Glimepiride, Rosiglitazone | 2006-06-27 | 2027-2028 | |
| Avandamet | Metformin, Rosiglitazone | 2003-10-20 | 2023-2035 | |
| Avandia | Rosiglitazone | 2000-07-11 | ||
| Axid | Nizatidine | 1988-04-12 | ||
| Dynacirc | Isradipine | 1990-12-20 | ||
| Evotopin | Topotecan | 1997-04-15 | 2024 | |
| Nyracta | Rosiglitazone | 2000-07-11 | ||
| Probenecid colchicine | Colchicine, Probenecid | 1982-01-01 | 2028-2037 | |
| Relafen | Nabumetone | 1991-12-24 | ||
| Venvia | Rosiglitazone | 2000-07-11 |
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use